FIELD: medicine, pharmaceutics.
SUBSTANCE: invention concerns pharmaceutics and development of new medicine based on interferon for treatment of infection and inflammatory diseases of periodontium and musculoskeletal system Substance of invention involves medicine containing human recombinant alpha and/or beta and/or gamma type interferon, substances from chondroprotection group -chondroitin sulfate and glucosamine, stimulating connective, cartilage and bone tissue and collagen synthesis and regeneration, preventin indicated tissue and collagen destruction due to collagenase, elastase and hyaluronidase activity suppression, as well as antibacterial and formation components with auxiliary substances. Complex medicine is made in the form of gel, ointment, cream or film.
EFFECT: enhanced efficiency, expanded action range of medicine.
6 cl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOMODULATING, ANTIVIRAL, ANTIBACTERIAL, ANTIOXIDATING, MEMBRANE STABILISING, ANTI-INFLAMMATORY, ANTITOXIC MEDICINAL AGENT FOR INFLAMMATORY-INFECTIOUS DISEASES | 2007 |
|
RU2327486C1 |
| HYPOALLERGENIC MEDICINAL AGENT APPLIED FOR TREATMENT OF INFECTION-INFLAMMATORY DISEASES OF DIFFERENT AETIOLOGY | 2007 |
|
RU2326688C1 |
| PHARAMCEUTICAL AGENT FOR TREATMENT OF VIRAL AND DIFFERENT INFECTIONS | 2006 |
|
RU2323738C1 |
| AGENT FOR SEVERE INFECTIOUS DISEASES AND MIXED INFECTIONS | 2008 |
|
RU2366450C1 |
| STABILISED IMMUNE-CORRECTIVE DRUG VIFERON-FORTE FOR TREATING INFECTIOUS-INFLAMMATORY DISEASES | 2008 |
|
RU2381812C1 |
| IMMUNOCORRECTIVE AGENT FOR TREATING DISEASES OF VIRAL AETIOLOGY | 2007 |
|
RU2411039C2 |
| PROLONGED INTERFERON SOLUTION | 2004 |
|
RU2270692C1 |
| CURATIVE AGENT | 2005 |
|
RU2283133C1 |
| RECTAL SUPPOSITORIES AND DEVICE FOR INTRODUCTION THEREOF | 1991 |
|
RU2024253C1 |
| OINTMENT | 1995 |
|
RU2114611C1 |
